| 发明名称 |
O-aryl glucoside SGLT2 inhibitors and method. |
| 摘要 |
whereinwhen Y isor heteroaryl;A is -O(CH2)m, S, -NH(CH2)m, or (CH2)n where n is 0-3 and m is 0-2;and R<1 >to R<6 >are as defined herein.A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with one, two or more other antidiabetic agents, and/or one, two or more hypolipidemic agents. |
| 申请公布号 |
ZA200207030(B) |
申请公布日期 |
2003.12.02 |
| 申请号 |
ZA20020007030 |
申请日期 |
2002.09.02 |
| 申请人 |
BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
WILLIAM N. WASHBURN;GANG WU;PHILIP M. SHER |
| 分类号 |
A61K31/137;A61K31/155;A61K31/18;A61K31/192;A61K31/195;A61K31/198;A61K31/216;A61K31/22;A61K31/351;A61K31/357;A61K31/365;A61K31/40;A61K31/4035;A61K31/404;A61K31/421;A61K31/4245;A61K31/426;A61K31/427;A61K31/4418;A61K31/445;A61K31/4453;A61K31/64;A61K31/7034;A61K31/7056;A61K31/706;A61K38/26;A61K38/28;A61K45/00;A61P3/04;A61P3/06;A61P3/10;A61P7/12;A61P9/10;A61P9/12;A61P13/12;A61P17/02;A61P25/00;A61P27/02;C07B61/00;C07H15/203;C07H15/26 |
主分类号 |
A61K31/137 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
